Thermo Scientific Dharmacon ON-TARGETplus sirna The Standard for sirna Specificity

Similar documents
Thermo Scientific Dharmacon sirna Libraries

岑 祥 股 份 有 限 公 司 技 術 專 員 費 軫 尹

Thermo Scientific DharmaFECT Transfection Reagents

Dicer Substrate RNAi Design

Relative Quantification of mirna Target mrnas by Real-Time qpcr. 1 Introduction. Gene Expression Application Note No. 4

Functional Analysis. mircury LNA microrna Mimics

Manual for: sirna-trans Maximo Reagent

TOOLS sirna and mirna. User guide

INTERFERin in vitro sirna/mirna transfection reagent PROTOCOL. 1 Standard sirna transfection of adherent cells... 2

OriGene Technologies, Inc. MicroRNA analysis: Detection, Perturbation, and Target Validation

HiPerFect Transfection Reagent Handbook

EXPRESSION ARREST shrna mir GENOME- WIDE LIBRARIES

MicroRNA formation. 4th International Symposium on Non-Surgical Contraceptive Methods of Pet Population Control

SmartFlare RNA Detection Probes: Principles, protocols and troubleshooting

sirna Duplexes & RNAi Explorer

PRODUCT INFORMATION...

Recombinant DNA and Biotechnology

Gene Silencing Oligos (GSOs) Third Generation Antisense

p21 Cell cycle arrest / genetic repair

Lezioni Dipartimento di Oncologia Farmacologia Molecolare. RNA interference. Giovanna Damia 29 maggio 2006

Diabetes and Drug Development

Frequently Asked Questions Next Generation Sequencing

HuCAL Custom Monoclonal Antibodies

Consistent Assay Performance Across Universal Arrays and Scanners

G E N OM I C S S E RV I C ES

LightSwitch Luciferase Assay System

Just the Facts: A Basic Introduction to the Science Underlying NCBI Resources

The world of non-coding RNA. Espen Enerly

TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298

PHCO 701 Short title Molecular Pharmacology Long title Introduction to Molecular Pharmacology

RNA Interference. - Localization - Labeling - Expression Profiling - In Vivo Delivery - Transfection

Product: Expression Arrest TM egfp control shrna vector

Technical Note: Analysis of microrna function using mircury LNA TM microrna Inhibitors

The Thermo Scientific KingFisher Family

Systematic discovery of regulatory motifs in human promoters and 30 UTRs by comparison of several mammals

User Manual/Hand book. qpcr mirna Arrays ABM catalog # MA003 (human) and MA004 (mouse)

Instructions. Torpedo sirna. Material. Important Guidelines. Specifications. Quality Control

micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved

Superior TrueMAB TM monoclonal antibodies for the recognition of proteins native epitopes

Outline. interfering RNA - What is dat? Brief history of RNA interference. What does it do? How does it work?

Validating Microarray Data Using RT 2 Real-Time PCR Products

Thermo Scientific ClinQuan MD Software For In Vitro Diagnostic Use. Confidence in Results With Data Integrity

13.4 Gene Regulation and Expression

Thermo Scientific PepFinder Software A New Paradigm for Peptide Mapping

Oncology Insights Enabled by Knowledge Base-Guided Panel Design and the Seamless Workflow of the GeneReader NGS System

Understanding the immune response to bacterial infections

M The Nucleus M The Cytoskeleton M Cell Structure and Dynamics

PATHOLOGY. HercepTestTM. Product Information

Clonetics Conditionally Immortalized Human Cells. Relevant Cells for High Throughput Screening

A role of microrna in the regulation of telomerase? Yuan Ming Yeh, Pei Rong Huang, and Tzu Chien V. Wang

Analyzing microrna Data and Integrating mirna with Gene Expression Data in Partek Genomics Suite 6.6

First Strand cdna Synthesis

Cell Discovery 360: Explore more possibilities.

Gene Expression Assays

RNAi Shooting the Messenger!

ncounter Leukemia Fusion Gene Expression Assay Molecules That Count Product Highlights ncounter Leukemia Fusion Gene Expression Assay Overview

The RNAi Consortium (TRC) Broad Institute

QIAGEN Transfection Technologies

Measuring Cell Viability/Cytotoxicity: Cell Counting Kit-F

Transfection-Transfer of non-viral genetic material into eukaryotic cells. Infection/ Transduction- Transfer of viral genetic material into cells.

Comparative genomic hybridization Because arrays are more than just a tool for expression analysis

MW (kd)

HRMS in Clinical Research: from Targeted Quantification to Metabolomics

CONTRACTING ORGANIZATION: University of Alabama at Birmingham Birmingham, AL 35294

HiPer RT-PCR Teaching Kit

CXCA-MSP. The next step in cervical cancer prevention! GynTect : Epigenetic biomarkers for reliable cancer diagnostics.

Microarray Technology

Interaktionen von RNAs und Proteinen

HuCAL Custom Monoclonal Antibodies

Quantifiler Human DNA Quantification Kit Quantifiler Y Human Male DNA Quantification Kit

Automated Nucleic Acid Extraction WorkStation Faster, cleaner,

Ion AmpliSeq Technology

RNAi. Martin Latterich

Primetime for KNIME:

Annexin V-FITC Apoptosis Detection Kit

hydrocortisone (5 mg/ml), EGF (10 µg/ml) and Heparin (5000 U/ml). Antibodies against the N-terminal peptide of MEK1 (MEK1-N) and against Flotillin 1

BaculoDirect Baculovirus Expression System Free your hands with the BaculoDirect Baculovirus Expression System

Thermo Scientific Prelude SPLC System FPO. Making LC/MS accessible. to clinical research and toxicology labs

Chapter 3. Protein Structure and Function

Biosafety considerations of new dsrna molecules

MAB Solut. MABSolys Génopole Campus 1 5 rue Henri Desbruères Evry Cedex. is involved at each stage of your project

ab Protein Sumoylation Assay Ultra Kit

PART 3.3: MicroRNA and Cancer

360 Master Mix. , and a supplementary 360 GC Enhancer.

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs

Module 3 Questions. 7. Chemotaxis is an example of signal transduction. Explain, with the use of diagrams.

Arabidopsis. A Practical Approach. Edited by ZOE A. WILSON Plant Science Division, School of Biological Sciences, University of Nottingham

Speed Matters - Fast ways from template to result

Pharmacology Curriculum Transition Present

Thermo Scientific Barnstead TII Pure Water Systems. Pure water. Pure research. Total confidence.

Innate Immunity. Insects rely solely on an innate immune system for defense against infection

Special report. Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006

Your partner in immunology

Transcription:

Thermo Scientific Dharmacon sirna The Standard for sirna Specificity Reduce off-targets up to 90% with the market-leading sirna Combine higher target specificity with guaranteed silencing Increase confidence in RNAi results with fewer false positives

The standard for sirna specificity Trust Thermo Scientific Dharmacon, the best-selling sirna in the world, to provide the most complete, proven solution for reducing off-target effects that may lead to toxicity or false phenotypes. Unique dual-strand modification pattern to reduce off-targets caused by either strand Thermo Scientific Dharmacon technology to decrease off-targets and enhance sirna effectiveness Seed region filters and seed frequency analysis for sirna designs to minimize off-target effects global market leader reagents provide the most specific silencing available A B 120 C 100 # Off-Target Genes 80 60 40 20 0 Unmodified sirna sirna Unmodified Individual sirna Individual sirna modifications reduce the overall number of off-targets, and pooling reduces them even further. Off-targets induced by the indicated sirna reagents targeting 5 genes were quantified by microarray analysis (Agilent 22K Platform). Panels A and B are representative examples of off-target signatures with and without application of modifications to (A) a single sirna and (B) a reagent. Panel C contains a boxplot of genes down-regulated by two-fold or more. Each box represents the middle 50% of the data set. Horizontal line in box: Median value of the data set. Vertical bars: minimum and maximum data values.

The only dual-strand sirna modification available for unmatched reduction in off-targets Studies have shown that both sirna strands participate in the silencing of unintended targets 1. Modifications that only promote antisense strand uptake may increase the number of off-targets caused by the antisense strand 2. A two-strand mechanism requires a two-strand solution that can only be found with the patent-pending modification pattern: Sense strand is modified to prevent uptake by RISC and favor antisense strand loading Antisense strand is modified to destabilize off-target activity and enhance target specificity two-strand solution modifications reduce off-targets better than sense strand inactivation alone Unmodified sirna CDH1 sirna modified for sense strand inactivation modified sirna GSK3B HSPE1 ERBB4 PPARa The modification pattern dramatically reduces off-targets. Off-target effects induced by the indicated sirna pools were quantified using microarray analysis. For each target, three different sirnas were used: unmodified, sense strandinactivated, and modified. Data shown represents genes down-regulated by twofold or more. HEK293 cells were transfected with 100 nm sirna using 0.2 µl of DharmaFECT 1. Data was analyzed at 24 hours. 0 10 20 30 40 50 60 # Off-Target Genes 1 Jackson, A.L., et al. Position-specific Chemical Modification Increases Specificity of sirna-mediated Gene Silencing. RNA 12.7(2006): 1197-1205. 2 Chen, P.Y et al. "Strand-specific 5'0-methylation of sirna duplexes controls guide strand selection and targeting specificity." RNA 2 (2008) 263-274.

Innovative bioinformatics advance sirna designs sirna utilizes groundbreaking peer-reviewed research from Dharmacon, published in 2006, which was the first to demonstrate that matches between an sirna seed region (positions 2-7 of antisense strand) and an mrna 3 untranslated region (UTR) are associated with off-target silencing. 1 Additional findings in 2008 demonstrate that the frequency of a given seed in 3 UTR regions is an indicator of its likelihood of causing off-targets. 2 Application of these findings to sirna designs set the standard for minimizing seed region-related off-targets of the antisense strand: Design filter excludes sirnas with common microrna seed-region motifs Known stress-inducing motifs are eliminated by design criteria Preference given to lower-frequency seed regions to minimize likelihood of mirna-like off-target effects groundbreaking research sirna designs with low-frequency seed regions ensure fewer off-targets 2 # Off-Target Genes 100 80 60 40 20 sirnas with low seed frequency have a significantly lower number of off-targets than sirnas with medium or high frequency seeds. Five sirnas with low, medium, or high frequency seed regions were transfected into HeLa cells and their associated offtarget signatures assessed via global expression profiling (Agilent 22K platform). sirna sequences were constant at positions 1 and 8-19, only the seed regions (positions 2-7) were altered (see below). Low frequency seeds: <350 occurrences in the HeLa transcriptome. Medium frequency: 2500-2800 occurrences. High frequency: >3800 occurrences. seed region of guide strand (positions 2-7) Figure adapted from Anderson et.al. See published citation for full experimental details. 0 Low Medium High Seed Frequency Class 5 seed region of guide strand (positions 2-7) 5' 3' 3 Antisense Strand 3 3' 5' Sense Strand 5 Antisense Stran Sense Strand 1 Birmingham, A., et al. 3 -UTR seed matches, but not overall identity, are associated with RNAi off -targets, Nature Methods. 3.3 (2006): 199-204. 2 Anderson, et al.: Experimental validation of the importance of seed frequency to sirna specificity. RNA 14.5 (2008).

reagents are proven to eliminate false phenotypes technology combines four highly potent sirnas to mimic the natural silencing pathway. Pooling reduces the concentration of each individual sirna, a widely accepted strategy for reducing off-target effects. The unequaled combination of superior bioinformatics, a unique, dual-strand chemical modification pattern, and the proven advantages of pooling results in a dramatic reduction of off-target effects. combines these proven strategies into a single sirna reagent, saving you time and money. Potent, guaranteed silencing with fewer off-targets that may confound true results Seed-region modifications and design optimization for the highest specificity available reagents reduce false negatives by targeting four different mrna regions at once superior bioinformatics sirna eliminates false phenotypes and maintains high potency ARPC1B mrna Levels (%) 120 100 80 60 40 20 0 sirna #1 sirna #2 sirna #3 sirna #4 sirna #1 sirna #2 sirna #3 sirna #4 Control Unmodified sirna Unmodified sirna sirna False phenotypes are alleviated by reagents while target gene knockdown is maintained. The effect of silencing ARPC1B on cell migration was studied in a breast cancer cell line. A monolayer of cells was uniformly scraped and the rate of cell migration to close the scrape (wound healing) was evaluated. Both unmodified and sirna reagents induced potent target knockdown. Inconsistent phenotypes due to off -target effects (red outline), were observed for cells transfected with unmodified individual sirnas. The unmodified improved the false phenotype considerably, while the significantly reduced off -target effects to produce a consistent phenotype. In collaboration with Kaylene Simpson, Laura Selfors and Joan Brugge, Harvard Medical School. sirna

Trust your screening results to the leader in RNAi technologies Only Dharmacon sirna product lines provide a single source, comprehensive toolset for successful, complete sirna screening. The practice of silencing a gene with multiple RNAi reagents is a standard technique for stratification of hits. reagents are a key component for high-confidence hit stratification by reducing false phenotypes resulting from off-target effects. No other provider has the breadth and scientific advantages of our sirna products: More guaranteed reagents per gene for highly efficient target silencing More strategies for enhanced specificity to reduce false results More product formats to support multiple screening workflows www.thermo.com/otp High-confidence screens with Dharmacon sirna reagents A B Primary Screen Identification of potential gene targets sigenome Option 1 Option 2 Dharmacon Duet sigenome and Hit Stratification Phenotypic confirmation with multiple reagents sigenome Set of 4 sirna Assign confidence of hits based on number of positive sirnas 2 pools positive Target Validation In-depth verification of biological role Multiple assays Primary cell types Phenotype rescue Stable cell lines In vivo studies Pathway mapping Workflow diagrams for highly effective sirna screen hit stratification. (A) Two options for hit stratification following primary screen with sigenome sirna reagents. (B) An emerging method for selection of highconfidence hits from a primary screen - the Dharmacon Duet approach. Carrying out an initial screen with two sirna reagents (sigenome and ) reduces experimental time and effort to select high-confidence hits and allows researcher to rapidly proceed to in-depth target validation. Relative Relative target target expression expression (%) 1.25 100 1 0.7575 0.550 0.2525 00 sigenome sirna reduces off-targets while maintaining potency in RNAi screens PIK4CA PTPRJ TESK1 MA PK3 A KA P11 STK39 A KT2 GSK3A ITGB1BP1 STK17A Target mrna knockdown in a screen with sigenome and sirna reagents was highly comparable, even at concentrations of. In extended studies, also was effective in reducing false phenotypes due to off-targets (manuscript in preparation).

Offering flexible formats to meet every experimental need Ordering information and related products are below. For contact information please see the back cover of this brochure. Products Description Amounts Available A mixture of four predesigned sirnas targeting one gene. Most recommended for potent gene knockdown. Guaranteed 75% target silencing. Sequence information provided. 5, 10, 20, 50 nmol Set of 4 sirnas or Individual sirnas Four individual sirnas from corresponding reagent. Guaranteed 75% target silencing by 3 of 4 sirnas. Sequence information provided. 4x2, 4x5, 4x10, 4x20 nmol 5, 10, 20, 50 nmol Available pre-defined sirna Libraries with sirna reagents Pre-defined sirna Libraries Apoptosis Cell Cycle Regulation Cytokine Receptors Deubiquinating Enzymes Druggable Genome Human Genome - NEW! GPCR Ion Channels Kinases Membrane Trafficking Nuclear Receptors Phosphatases Proteases Ubiquitin Conjugation - subset 1 Ubiquitin Conjugation - subset 2 Ubiquitin Conjugation - subset 3 0.5, 1, 2 nmol Custom sirna Libraries Custom human and mouse sirna libraries available for your list of genes. Available as or set of four individual sirna reagents per gene target. 0.5, 1, 2 nmol/ reagent Custom Design and Synthesis Our specialists will design and synthesize an optimal for your particular needs (non-standard species, gene variant-specific silencing, etc.) 50 nmol Custom sirna Synthesis Already have your sirna sequence? Have it synthesized with modifications to improve overall silencing specificity. In vivo processing and HPLC purification available. 20, 40, 100 nmol (>100 nmol, please inquire) sirna Control Reagents Positive sirna controls with reduced off-targets, validated to work in multiple cell lines. Negative controls are microarray confirmed to have nearly undetectable silencing in human cells. 5, 20 nmol

Thermo Scientific Dharmacon sirna Contact Information North America 2650 Crescent Dr., Suite 100 Lafayette, CO 80026 Toll free: 800 235 9880 Tel: 303 604 9499 Fax: 303 604 3286 US web: www.thermo.com/dharmacon US e-mail: dharmacon.lab@thermofisher.com Other Countries: Technical support: 00800 73724648 Belgium Tel: 0800 80543 Fax: 0800 80178 Technical support: 053 85 71 92 France Tel: 08009 14294 Fax: 08009 11885 Technical support: 0800 50 84 97 Germany Tel: 0800 1830746 Fax: 0800 1810366 Technical support: 0228 2427409 The Netherlands Tel: 08000 223464 Fax: 08000 223291 Technical support: 076 50 31 880 United Kingdom Tel: 08009 171501 Fax: 01372 840545 Technical support: 0800 252 185 Switzerland Tel: 08005 63505 Fax: 08008 38669 Technical support: 0800 56 31 40 US Literature # 00121-06-H-03-U Euro Literature # PB 2008 15 2009 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific Inc. and its subsidiaries.